ASXL1 and acute myeloid leukemia: The expression levels of ASXL1 in AML patients was not significantly differentfrom normal subjects (Figure 1A), however,transcript levels showed a significant increase in 28 patients (52%) with RQrange from 1.62 to 16, while it exhibited a reduction in 13 patients (24%) witha RQ range from 0.065 to 0.9 (Figure 1A andFigure 5).